Biblio Discovery — Demo Discovery Service

7 hasil untuk "Christopher Power"

Menampilkan 1–7 · 0,23 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Anti-inflammatory effects of moxifloxacin and levofloxacin on cadmium-activated human astrocytes: Inhibition of proinflammatory cytokine release, TLR4/STAT3, and ERK/NF-κB signaling pathway

    Suttinee Phuagkhaopong; Jidapha Sukwattanasombat; Kran Suknuntha dkk.

    PLOS ONE, Vol. 20 No. 1 · 2025 · Inggris · PLOS Scopus

    Cadmium is a non-essential element and neurotoxin that causes neuroinflammation, which leads to neurodegenerative diseases and brain cancer. To date, there are no specific or effective therapeutic agents to control inflammation and alleviate cadmium-induced progressive destruction of brain cells…

  2. Artikel Jurnal Teks lengkap

    Age- and Disease-Dependent HERV-W Envelope Allelic Variation in Brain: Association with Neuroimmune Gene Expression

    Rakesh K. Bhat; Kristofor K. Ellestad; B. Matt Wheatley dkk.

    PLoS ONE, Vol. 6 No. 4 · 2011 · Inggris · PLOS Scopus

    Background: The glycoprotein, Syncytin-1, is encoded by a human endogenous retrovirus (HERV)-W env gene and is capable of inducing neuroinflammation. The specific allele(s) responsible for Syncytin-1 expression in the brain is uncertain. Herein, HERV-W env diversity together with Syncytin-1…

  3. Artikel Jurnal Teks lengkap

    MicroRNAs upregulated during HIV infection target peroxisome biogenesis factors: Implications for virus biology, disease mechanisms and neuropathology

    Zaikun Xu; Eugene L. Asahchop; William G. Branton dkk.

    PLOS Pathogens, Vol. 13 No. 6 · 2017 · Inggris · PLOS Scopus

    HIV-associated neurocognitive disorders (HAND) represent a spectrum neurological syndrome that affects up to 25% of patients with HIV/AIDS. Multiple pathogenic mechanisms contribute to the development of HAND symptoms including chronic neuroinflammation and neurodegeneration. Among the factors…

  4. Artikel Jurnal Teks lengkap

    Human Endogenous Retrovirus-K(II) Envelope Induction Protects Neurons during HIV/AIDS

    Rakesh K. Bhat; Wallis Rudnick; Joseph M. Antony dkk.

    PLoS ONE, Vol. 9 No. 7 · 2014 · Inggris · PLOS Scopus

    Human endogenous retroviruses (HERVs) are differentially expressed depending on the cell type and physiological circumstances. HERV-K has been implicated in the pathogenesis of several diseases although the functional consequences of its expression remain unknown. Human immunodeficiency virus (HIV)…

  5. Artikel Jurnal Teks lengkap

    Hepatitis C Virus Core Protein Induces Neuroimmune Activation and Potentiates Human Immunodeficiency Virus-1 Neurotoxicity

    Pornpun Vivithanaporn; Ferdinand Maingat; Liang-Tzung Lin dkk.

    PLoS ONE, Vol. 5 No. 9 · 2010 · Inggris · PLOS Scopus

    Background: Hepatitis C virus (HCV) genomes and proteins are present in human brain tissues although the impact of HIV/HCV co-infection on neuropathogenesis remains unclear. Herein, we investigate HCV infectivity and effects on neuronal survival and neuroinflammation in conjunction with HIV…

  6. Artikel Jurnal Teks lengkap

    Brain Microbial Populations in HIV/AIDS: α-Proteobacteria Predominate Independent of Host Immune Status

    William G. Branton; Kristofor K. Ellestad; Ferdinand Maingat dkk.

    PLoS ONE, Vol. 8 No. 1 · 2013 · Inggris · PLOS Scopus

    The brain is assumed to be a sterile organ in the absence of disease although the impact of immune disruption is uncertain in terms of brain microbial diversity or quantity. To investigate microbial diversity and quantity in the brain, the profile of infectious agents was examined in pathologically…

  7. Artikel Jurnal Teks lengkap

    Factors in AIDS Dementia Complex Trial Design: Results and Lessons from the Abacavir Trial

    Bruce J Brew; Mark Halman; Jose Catalan dkk.

    PLoS Clinical Trials, Vol. 2 No. 3 · 2007 · Inggris · PLOS

    Objectives: To determine the efficacy of adding abacavir (Ziagen, ABC) to optimal stable background antiretroviral therapy (SBG) to AIDS dementia complex (ADC) patients and address trial design. Design: Phase III randomized, double-blind placebo-controlled trial. Setting: Tertiary outpatient…